Moreover, the anticancer effects and related mechanisms of ginsenoside Rh2 in various cancer cells have been demonstrated, including its promotion of the apoptosis of related genes in cancer cells by regulating the Bax and Bcl-2 pathway, activating the mitochondrial apoptotic pathway, affecting the intracellular redox balance by the generation of ROS (reactive oxygen species), etc. Therefore, further study into the anticancer mechanisms of our novel ginsenoside is feasible, based on the existing theoretical evidence. Here, BCL2 is linked to cancer.